X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16) 16
Publication (9) 9
Newspaper Article (4) 4
Book Review (2) 2
Book / eBook (1) 1
Paper (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (11) 11
female (10) 10
male (10) 10
aged (9) 9
article (8) 8
clinical neurology (8) 8
middle aged (6) 6
abridged index medicus (5) 5
intracerebral hemorrhage (5) 5
magnetic resonance imaging (5) 5
microbleeds (5) 5
aged, 80 and over (4) 4
cerebral hemorrhage - diagnostic imaging (4) 4
small vessel disease (4) 4
adult (3) 3
amyloid angiopathy (3) 3
analysis (3) 3
apolipoprotein-e genotype (3) 3
cerebral amyloid angiopathy - complications (3) 3
cerebral amyloid angiopathy - diagnostic imaging (3) 3
cerebral hemorrhage - complications (3) 3
cerebral hemorrhage - epidemiology (3) 3
cerebral hemorrhage - pathology (3) 3
leukoaraiosis (3) 3
logistic models (3) 3
medicine & public health (3) 3
oncology (3) 3
pharmacology & pharmacy (3) 3
pharmacology/toxicology (3) 3
prevalence (3) 3
prospective studies (3) 3
recurrent intracerebral hemorrhage (3) 3
white-matter lesions (3) 3
120 (2) 2
advanced cancer (2) 2
angiogenesis (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
anticoagulation (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antithrombotic therapy (2) 2
apolipoproteins e - genetics (2) 2
atrial-fibrillation (2) 2
bevacizumab (2) 2
cerebral (2) 2
cerebral hemorrhage - etiology (2) 2
cerebral small vessel diseases - complications (2) 2
cerebral small vessel diseases - diagnostic imaging (2) 2
cohort (2) 2
cohort studies (2) 2
cortical superficial siderosis (2) 2
diagnosis, differential (2) 2
everolimus (2) 2
growth-factor (2) 2
hypertension - complications (2) 2
hypertension - diagnostic imaging (2) 2
insights (2) 2
macrobleed (2) 2
magnetic resonance imaging - methods (2) 2
maximum tolerated dose (2) 2
microbleed (2) 2
neurosciences (2) 2
phase i (2) 2
renal-cell carcinoma (2) 2
research (2) 2
risk (2) 2
risk factors (2) 2
severity of illness index (2) 2
stroke - complications (2) 2
stroke prevention (2) 2
sulcal siderosis (2) 2
white matter - diagnostic imaging (2) 2
1974-1977 (1) 1
1st global approval (1) 1
7 (1) 1
activated factor-vii (1) 1
activation (1) 1
administration, oral (1) 1
advocacy (1) 1
akt (1) 1
alzheimer-disease (1) 1
alzheimers-disease (1) 1
american academy (1) 1
amyotrophic-lateral-sclerosis (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiography spot sign (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
anticancer agents (1) 1
anticoagulants (1) 1
anticoagulants - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
arteriopathy (1) 1
association (1) 1
atherosclerosis (1) 1
athletes (1) 1
behavior (1) 1
biochemistry, general (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Muscle & Nerve, ISSN 0148-639X, 11/2017, Volume 56, Issue 5, pp. 848 - 858
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2012, Volume 70, Issue 2, pp. 251 - 258
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2014, Volume 32, Issue 2, pp. 330 - 339
Purpose Dasatinib inhibits src family kinases and has anti-angiogenic properties. We conducted a phase I study of dasatinib, capecitabine, oxaliplatin, and... 
Dasatinib | Medicine & Public Health | Src | Oncology | Pharmacology/Toxicology | Metastatic colorectal cancer | Bevacizumab | ACTIVATION | CARCINOMA CELLS | EFFICACY | TYROSINE KINASE | PROLIFERATION | FAMILY KINASE INHIBITOR | ONCOLOGY | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | EXPRESSION | C-SRC | PP60C-SRC | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thiazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Thiazoles - adverse effects | Angiogenesis Inhibitors - administration & dosage | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | src-Family Kinases - metabolism | Adult | Deoxycytidine - adverse effects | Female | Angiogenesis Inhibitors - adverse effects | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal, Humanized - adverse effects | Fluorouracil - analogs & derivatives | Pyrimidines - administration & dosage | Deoxycytidine - administration & dosage | Vascular Endothelial Growth Factor A - immunology | Biomarkers, Tumor - blood | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Pyrimidines - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Complications and side effects | Dosage and administration | Research | Drug therapy | Colorectal cancer | Studies | Clinical trials | Metastasis | Pharmaceutical sciences | Index Medicus | bevacizumab | metastatic colorectal cancer | dasatinib | src
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 07/2018, Volume 23, Issue 7, pp. 782 - 790
This article reports a phase I dose‐escalation study conducted to determine the maximum tolerated dose and recommended phase II dose and to preliminarily... 
Ganitumab | Advanced cancer | Phase I | Everolimus | Panitumumab | TARGET | ANGIOGENESIS | RECEPTOR | AKT | RENAL-CELL CARCINOMA | INHIBITION | ONCOLOGY | THERAPIES | GROWTH-FACTOR | CLINICAL-MODEL | COUNTERACT | Gastrointestinal Cancer
Journal Article
European Physical Journal C: Particles and Fields, ISSN 1434-6044, 10/2012, Volume 73, p. 2283
Eur. Phys. J. C 73 (2013) 2283 A measurement of the inclusive WW+WZ diboson production cross section in proton-proton collisions is reported, based on events... 
Physics - High Energy Physics - Experiment | Physics | High Energy Physics - Experiment
Journal Article
06/2019
Disclosed herein are synthetic particles that are shaped like red blood cells. The particles include pectin and oligochitosan and optionally a bioactive agent.... 
HYGIENE | METALLURGY | PEPTIDES | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Current Cardiology Reports, ISSN 1523-3782, 12/2013, Volume 15, Issue 12, pp. 1 - 7
Intracerebral hemorrhage (ICH, or macrobleeds) and cerebral microbleeds—smaller foci of hemosiderin deposits commonly detected by magnetic resonance imaging of... 
Microbleed | Stroke prevention | Medicine & Public Health | Antithrombotic therapy | Cerebral | Anticoagulation | Sulcal Siderosis | Cardiology | Leukoaraiosis | Intracerebral hemorrhage | Macrobleed | ALZHEIMER-DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | LOBAR | ATRIAL-FIBRILLATION | WHITE-MATTER LESIONS | SUPERFICIAL SIDEROSIS | RECURRENT INTRACEREBRAL HEMORRHAGE | WARFARIN | AMYLOID ANGIOPATHY | SPATIAL-DISTRIBUTION | Cerebral Amyloid Angiopathy - epidemiology | Leukoencephalopathies - epidemiology | United States - epidemiology | Siderosis - drug therapy | Stroke - prevention & control | Humans | Risk Factors | Cerebral Amyloid Angiopathy - prevention & control | Leukoencephalopathies - prevention & control | Stroke - complications | Male | Stroke - drug therapy | Anticoagulants - adverse effects | Siderosis - epidemiology | Patient Selection | Leukoencephalopathies - drug therapy | Cerebral Hemorrhage - epidemiology | Functional Neuroimaging | Cerebral Amyloid Angiopathy - drug therapy | Cerebral Hemorrhage - prevention & control | Female | Siderosis - prevention & control | Cerebral Hemorrhage - etiology | Care and treatment | Anticoagulants (Medicine) | Thromboembolism | Cardiovascular agents | Index Medicus | intracerebral hemorrhage | macrobleed | microbleed | anticoagulation | antithrombotic therapy | leukoaraiosis | sulcal siderosis | stroke prevention | cerebral
Journal Article